One dose of oral hexarelin protects chronic cardiac function after myocardial infarction.

Abstract

Both hexarelin and its natural analog ghrelin exert comparable cardioprotective activities. A single dose of ghrelin administered at the very acute phase after experimental myocardial infarction positively affects cardiac function in chronic heart failure. Therefore, this study aimed to determine whether a single dose of oral hexarelin has the same effect in the chronic disease phase. Myocardial infarction or sham operation was generated by left coronary artery ligation in male C57BL/6J mice, which subsequently received one dose of hexarelin or vehicle treatment by oral gavage 30 min after operation. Although the mortality within 14 days after myocardial infarction did not differ between the groups, hexarelin treatment protected cardiac function in the chronic phase as evidenced by higher ejection fraction and fractional shortening, as well as lower lung weight/body weight and lung weight/tibial length ratios, compared with vehicle treatment. Hexarelin treatment concurrently lowered plasma epinephrine and dopamine levels, and shifted the balance of autonomic nervous activity toward parasympathetic nervous activity as evidenced by a smaller low/high-frequency power ratio and larger normalized high-frequency power on heart rate variability analysis. The results first demonstrate that one dose of oral hexarelin treatment potentially protects chronic cardiac function after acute myocardial infarction, and implicate that activating growth hormone secretagogue receptor 1a might be beneficial for cardioprotection, although other mechanism may also be involved.

• Authors: Yuanjie Mao, Takeshi Tokudome, Ichiro Kishimoto, Kentaro Otani, Mikiya Miyazato, Kenji Kangawa
• Journal: Peptides (Peptides) Vol. 56 Pg. 156-62 (Jun 2014) ISSN: 1873-5169 [Electronic] United States
• PMID: 24747279 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2014 Elsevier Inc. All rights reserved.

Chemical References

• Oligopeptides
• hexarelin
• Dopamine
• Norepinephrine
• Epinephrine

Topics

• Administration, Oral
• Animals
• Dopamine (blood)
• Epinephrine (blood)
• Heart Rate (drug effects)
• Male
• Mice
• Mice, Inbred C57BL
• Myocardial Infarction (drug therapy)
• Norepinephrine (blood)
• Oligopeptides (administration & dosage, therapeutic use)